Whole-brain radiation therapy in melanoma: an open question

The Lancet Oncology

Volumn 11, Issue 1, 2010, Pages 13-

  Cranmer, Lee D ^a   Jeter, Joanne M ^a   Morgan, Sherif S ^a   Hersh, Evan M ^a   Stea, Baldassarre ^b  

^a UNIVERSITY OF ARIZONA   (United States)

^b UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN METASTASIS; BRAIN RADIATION; CANCER PATIENT; CANCER RECURRENCE; CLINICAL TRIAL; COGNITIVE DEFECT; HUMAN; KIDNEY CARCINOMA; LETTER; LUNG NON SMALL CELL CANCER; MELANOMA; OVERALL SURVIVAL; PATIENT CARE PLANNING; PATIENT SELECTION; PRIORITY JOURNAL; RISK BENEFIT ANALYSIS; STEREOTACTIC RADIOSURGERY; WHOLE BRAIN RADIATION THERAPY;

EID: 73249117664     PISSN: 14702045     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1470-2045(09)70346-8     Document Type: Letter

References (4)

1. Chang E.L., Wefel J.S., Hess K.R., et al. Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trial. Lancet Oncol 10 (2009) 1037-1044
2. Chang E.L., Selek U., Hassenbusch III S.J., et al. Outcome variation among "radioresistant" brain metastases treated with stereotactic radiosurgery. Neurosurgery 56 (2005) 936-945
3. Skibber J., Soong S.-j., Austin L., Balch C., and Sawaya R. Cranial irradiation after surgical excision of brain metastases in melanoma patients. Ann Surg Oncol 3 (1996) 118-123
4. Lin N.U., and Winer E.P. Brain metastases: the HER2 paradigm. Clin Cancer Res 13 (2007) 1648-1655